Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organogenesis Holdings (ORGO) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Organogenesis Holdings (ORGO) over the last 10 years, with Q3 2025 value amounting to $126.9 million.

  • Organogenesis Holdings' Shares Outstanding (Weighted Average) fell 429.46% to $126.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $126.9 million, marking a year-over-year decrease of 429.46%. This contributed to the annual value of $131.7 million for FY2024, which is 33.68% up from last year.
  • Per Organogenesis Holdings' latest filing, its Shares Outstanding (Weighted Average) stood at $126.9 million for Q3 2025, which was down 429.46% from $126.9 million recorded in Q2 2025.
  • In the past 5 years, Organogenesis Holdings' Shares Outstanding (Weighted Average) ranged from a high of $132.6 million in Q3 2024 and a low of $126.3 million during Q1 2025
  • Its 5-year average for Shares Outstanding (Weighted Average) is $129.8 million, with a median of $130.1 million in 2022.
  • Per our database at Business Quant, Organogenesis Holdings' Shares Outstanding (Weighted Average) soared by 2246.15% in 2021 and then tumbled by 431.43% in 2025.
  • Quarter analysis of 5 years shows Organogenesis Holdings' Shares Outstanding (Weighted Average) stood at $128.3 million in 2021, then rose by 1.36% to $130.1 million in 2022, then grew by 0.89% to $131.2 million in 2023, then increased by 0.34% to $131.7 million in 2024, then fell by 3.64% to $126.9 million in 2025.
  • Its last three reported values are $126.9 million in Q3 2025, $126.9 million for Q2 2025, and $126.3 million during Q1 2025.